← Back to Bills
HR 8663118th CongressFailed / ExpiredHouse

DETECT Fentanyl and Xylazine Act of 2024

Policy Area: Science, Technology, Communications
View on Congress.gov
Origin Chamber
House
Last Updated
Dec 6, 2025
Latest Action Date
Dec 23, 2024

Latest Action

Became Public Law No: 118-186.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The DETECT Fentanyl and Xylazine Act of 2024 is a congressional bill from the 118th Congress, originating in the House of Representatives. The bill is related to the policy area of Science, Technology, and Communications. It aims to address issues related to fentanyl and xylazine detection, though no official summary or full text is available in the source data. The bill became Public Law No: 118-186 on December 23, 2024, indicating it was enacted into law despite the status field indicating 'Failed / Expired,' which may reflect a data inconsistency.

Bottom Line

This bill was enacted into law in late 2024 to address fentanyl and xylazine detection, but detailed provisions and implementation specifics are not available in the provided data.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill focuses on fentanyl and xylazine detection, substances of concern in public health and safety.
  • It was introduced in the House during the 118th Congress as H.R. 8663.
  • The latest recorded action shows it became Public Law No: 118-186 on December 23, 2024.
Who Benefits?

['Federal agencies involved in drug enforcement and public health monitoring', 'Communities affected by fentanyl and xylazine use', 'Science and technology sectors focused on drug detection technologies']

Potential Concerns

['Lack of available full bill text and official summary limits understanding of implementation details and scope.', 'Potential costs associated with developing and deploying detection technologies are unknown.', 'Oversight and enforcement mechanisms cannot be assessed without detailed provisions.']

Political Context

The bill was introduced and passed during the 118th Congress, reflecting ongoing legislative efforts to address the opioid crisis and related drug threats through scientific and technological means. The absence of a summary and full text in the source data limits detailed contextual analysis.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

['Improved detection capabilities for fentanyl and xylazine could enhance public health responses and law enforcement effectiveness.', 'Potential stimulation of research and development in drug detection technologies.', 'Possible increased resource allocation to agencies responsible for implementing detection measures.']

GovScope Watchdog Notes

The absence of an official summary and full text in the source data limits transparency and public oversight. Additionally, conflicting status information may cause confusion about the bill's legislative outcome. Ensuring accurate and complete legislative records is essential for government transparency and informed public discourse.

Passage Likelihood: HighConfidence: 75%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready